Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0T2ZQ
|
||||
Former ID |
DIB012892
|
||||
Drug Name |
Felbinac prodrug
|
||||
Synonyms |
Daitac; Napageln; Seltouch; BPAA acyl ester; Felbinac prodrug (liposomal); LM-001; Lipo-BPAA; Felbinac prodrug (liposomal), Lederle
|
||||
Indication | Inflammatory disease [ICD9: 140-229, 147, 173, 573.3, 710-719; ICD10:C11, C44, K75.9, M00-M25] | Preclinical | [546514] | ||
Company |
Wyeth KK
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
C(=O)(Cc1ccc(c2ccccc2)cc1)OCC
|
||||
CAS Number |
CAS 14062-23-8
|
||||
Target and Pathway | |||||
Target(s) | Cyclooxygenase | Target Info | Modulator | [550035], [551871] | |
References | |||||
Ref 550035 | Predicting Cyclooxygenase Inhibition by Three??imensional Pharmacophoric Profiling. Part I: Model Generation, Validation and Applicability in Ethnopharmacology. Molecular Informatics 01/2010; 29(1??):75 - 86. | ||||
Ref 551871 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.